Larimar director granted 55,150 stock options
Larimar Therapeutics, Inc. director Joseph Truitt reported receiving a stock option grant covering 55,150 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Larimar Therapeutics, Inc. director Joseph Truitt reported receiving a stock option grant covering 55,150 shares of common stock. The option has an exercise price of $3.33 per share and expires on May 19, 2036.
These options vest on the earlier of May 19, 2027, or the date of Larimar’s next annual meeting of stockholders, in each case contingent on Truitt’s continued service on the Board of Directors. Following this grant, Truitt holds 55,150 stock options directly.
Insider Trade Summary
Grant/Award: 55,150 shares
Grant/Award
1 txn
Insider
Truitt Joseph
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 55,150 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 55,150 contracts (Direct)
Footnotes (1)
- F1. The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.
Key Figures
Options granted: 55,150 options
Exercise price: $3.33 per share
Expiration date: May 19, 2036
+3 more
6 metrics
Options granted
55,150 options
Stock Option (Right to Buy) grant to director
Exercise price
$3.33 per share
Conversion or exercise price of options
Expiration date
May 19, 2036
Option term end date
Vesting date trigger
May 19, 2027 or next annual meeting
Earlier date governs vesting, subject to board service
Post-transaction options held
55,150 options
Total derivative securities following transaction
Transaction code
Code A
Grant, award, or other acquisition on Form 4
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, Common Stock, Board of Directors, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Board of Directors financial
"subject to the Reporting Person's continued service on the Board of Directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
annual meeting of stockholders financial
"the date of the Company's next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Larimar Therapeutics (LRMR) disclose for Joseph Truitt?
Larimar Therapeutics disclosed that director Joseph Truitt received a grant of 55,150 stock options. These derivative securities give him the right to buy common stock at a fixed price under the company’s equity compensation arrangements.
How many Larimar Therapeutics (LRMR) options were granted to Joseph Truitt and at what price?
Joseph Truitt was granted 55,150 stock options, each with an exercise price of $3.33 per share. This means he can purchase Larimar common stock at $3.33 once the options vest and before they expire, subject to the grant’s terms.
When do Joseph Truitt’s Larimar Therapeutics (LRMR) stock options vest?
The options vest on the earlier of May 19, 2027 or the date of Larimar’s next annual meeting of stockholders. Vesting in both cases is conditioned on Truitt’s continued service on the company’s Board of Directors through that date.
What is the expiration date of Joseph Truitt’s Larimar Therapeutics (LRMR) stock options?
Joseph Truitt’s stock options expire on May 19, 2036. After that expiration date, any unexercised options will lapse and can no longer be used to purchase Larimar Therapeutics common stock at the $3.33 exercise price specified in the grant.
What type of Form 4 transaction code applies to Joseph Truitt’s LRMR option grant?
The transaction is coded “A” on Form 4, indicating a grant, award, or other acquisition of derivative securities. This reflects an options award rather than an open-market stock purchase or sale by Joseph Truitt.
How many Larimar Therapeutics (LRMR) derivative securities does Joseph Truitt hold after this grant?
After this transaction, Joseph Truitt holds 55,150 stock options directly, according to the reported total shares following the transaction. Each option is exercisable for one share of Larimar Therapeutics common stock under the grant terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
